The company's low P/S ratio and declining revenue could worry investors. If top-line growth doesn't improve, the P/S could fall further. The company's declining revenue is a key factor in its low P/S ratio. If recent medium-term revenue trends continue, the share price may remain stagnant.
Emerson's acquisition of NI is expected to expand customer services, shareholder value, and endorse organic revenue growth towards 4-7%. With Ritu Favre as president, the Test & Measurement business remains in Austin, projecting continued growth.
奥斯汀科技集团股票讨论区
$SeaStar Medical(ICU.US)$ $Trxade Health(MEDS.US)$ $尚高生命科学(SISI.US)$ $奥斯汀科技集团(OST.US)$ $微美全息(WIMI.US)$ $Intuitive Machines(LUNR.US)$
📊⚡️📊
暂无评论